Drug
Desmoteplase
Desmoteplase is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
83.3%
Based on 5 completed trials
Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_1
1
17%
Ph phase_2
2
33%
Ph phase_3
3
50%
Phase Distribution
1
Early Stage
2
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
3(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
83.3%
5 of 6 finished
Non-Completion Rate
16.7%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Terminated(1)
Detailed Status
Completed5
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 33 (50.0%)
Trials by Status
terminated117%
completed583%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
NCT01104467
terminatedphase_3
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
NCT00856661
completedphase_3
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
NCT00790920
completedphase_3
Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)
NCT00111852
completedphase_2
Desmoteplase in Acute Ischemic Stroke (DIAS)
NCT00638781
Clinical Trials (6)
Showing 6 of 6 trials
NCT01104467Phase 2
Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
NCT00856661Phase 3
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
NCT00790920Phase 3
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
NCT00111852Phase 3
Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)
NCT00638781Phase 2
Desmoteplase in Acute Ischemic Stroke (DIAS)
NCT00638248Phase 1
Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6